Introduction to Advanced Nanomedicine in Neurology

Central nervous system (CNS) diseases often result in irreversible damage because inflammatory factors trigger chronic injuries within complex neural architectures. Unfortunately, the blood-brain barrier (BBB) naturally prevents many traditional drugs from reaching their intended targets. To address this medical challenge, researchers are exploring single-atom nanozymes (SAzymes) as a revolutionary therapeutic platform. These advanced materials feature atomic-level dispersion of active sites, ensuring maximum atom utilization and highly tunable chemical environments.

Advantages of Single-Atom Nanozymes in Medicine

Compared to traditional nanozymes, these single-atom platforms exhibit significantly higher catalytic activity. Furthermore, they allow scientists to decipher complex structure-activity relationships more effectively than bulk materials. Because of their high tunability, researchers can optimize these active sites for specific neurological applications. Therefore, these materials—which include carbon-based structures, metal-organic frameworks (MOFs), and metal oxides—offer a more precise approach to drug design.

Role of Single-atom Nanozymes in Neuroprotection

Recent evidence highlights the powerful anti-inflammatory and antibacterial properties of these single-atom systems. Consequently, clinicians are investigating the role of various SAzymes in treating brain injury, stroke, and neurodegenerative diseases. Additionally, these nanozymes serve as vital tools for biological monitoring and long-term neuroprotection. By leveraging their unique atomic structures, scientists can now propose novel therapeutic strategies that were previously impossible to achieve with conventional pharmacology.

Future Directions and Challenges

While the potential for SAzymes is vast, several key challenges remain regarding their clinical translation. Researchers must still conduct in-depth analyses of long-term toxicity and large-scale synthesis methods. However, the superior catalytic properties and the ability to cross biological barriers suggest that single-atom nanozymes will remain a hot topic in neurological research for years to come.

Frequently Asked Questions

What are single-atom nanozymes (SAzymes)?

SAzymes are a class of nanomaterials where the active metal sites are atomically dispersed on a support, providing high catalytic efficiency similar to natural enzymes.

How do SAzymes benefit the treatment of CNS diseases?

They offer superior anti-inflammatory and antibacterial properties and can be engineered to cross the blood-brain barrier more effectively than many standard drugs.

What materials are used to create these nanozymes?

Common materials include carbon-based nanostructures, metal-organic frameworks (MOFs), metal oxides, and metal sulfides, each offering unique coordination environments for the active metal atoms.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Yang Y et al. Single-atom nanozymes: a new platform for central nervous system disease research. Chem Commun (Camb). 2026 Feb 10. doi: 10.1039/d6cc00053c. PMID: 41664999.

Wei W. Single-atom nanozymes towards central nervous system diseases. Nano Res. 2023;16(4):4500-4515.

Zhang S et al. Strategies to improve the blood-brain barrier penetration of nanozymes. Theranostics. 2023;13(8):2494-2510.